Katie King

Katie King transforms the way we think about pharmaceutical manufacturing by literally reaching for the stars. As Co-founder & CEO of BioOrbit, she leads groundbreaking efforts to produce critical medical compounds in zero-gravity environments, where the unique conditions of space offer unprecedented opportunities for pharmaceutical innovation.

King's vision extends far beyond traditional drug development. Her startup focuses specifically on cancer treatment applications, developing methods to manufacture medications in microgravity that could prove more effective and precise than their Earth-bound counterparts.

This revolutionary approach challenges conventional pharmaceutical manufacturing and opens new frontiers in medical research. By leveraging space technology and biotechnology, King's work at BioOrbit represents a bold reimagining of how life-saving medications could be developed and produced, potentially offering new hope for cancer patients worldwide through the untapped potential of space-based manufacturing.